TABLE 5.
Patient and investigator global satisfaction with treatment
|
Baseline
|
Week 8
|
||||||
|---|---|---|---|---|---|---|---|
| ICS | ICS/LABA | Total | ICS | ICS/LABA | Total | P* | |
| Patient global satisfaction with treatment, n (%) | |||||||
| Very satisfied | 8 (5.2) | 15 (9.8) | 24 (7.7) | 64 (42.4) | 70 (47.9) | 136 (45.2) | |
| Satisfied | 31 (20.1) | 45 (29.4) | 77 (24.6) | 56 (37.1) | 51 (34.9) | 110 (36.5) | |
| Neither satisfied nor dissatisfied | 49 (31.8) | 52 (34.0) | 104 (33.2) | 17 (11.3) | 13 (8.9) | 36 (12.0) | <0.001 |
| Dissatisfied | 60 (39.0) | 36 (23.5) | 97 (31.0) | 14 (9.3) | 11 (7.5) | 16 (5.3) | |
| Very dissatisfied | 6 (3.9) | 5 (3.3) | 11 (3.5) | 0 (0.0) | 1 (0.7) | 1 (0.3) | |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.7) | |
| Total, n | 154 | 153 | 313 | 151 | 146 | 301 | |
| Investigator global satisfaction with treatment, n (%) | |||||||
| Very satisfied | 3 (1.9) | 4 (2.6) | 7 (2.2) | 69 (45.7) | 65 (44.5) | 135 (44.9) | |
| Satisfied | 19 (12.3) | 34 (22.2) | 54 (17.3) | 51 (33.8) | 58 (39.7) | 110 (36.5) | |
| Neither satisfied nor dissatisfied | 47 (30.5) | 53 (34.6) | 104 (33.2) | 20 (13.2) | 15 (10.3) | 30 (10.0) | <0.001 |
| Dissatisfied | 84 (54.5) | 57 (37.3) | 142 (45.4) | 9 (6.0) | 7 (4.8) | 25 (8.3) | |
| Very dissatisfied | 1 (0.6) | 3 (2.0) | 4 (1.3) | 0 (0.0) | 1 (0.7) | 1 (0.3) | |
| Missing | 0 (0.0) | 2 (1.3) | 2 (0.6) | 2 (1.3) | 0 (0.0) | 0 (0.0) | |
*
Based on the McNemar-Bowker test for total and for the inhaled corticosteroid (ICS) and ICS/long-acting beta-2-agonist (LABA) groups